Skip to content

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-19 - Adalimumab

open

Techniker Krankenkasse · 992-80116-93

Read the notice at ted-eu ↗

Value
unstated
Published
18 Nov 2026
Deadline
31 Dec 2026, 22:58 GMT · 44d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600

Description

Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Adalimumab im Rahmen eines Open-House-Verfahrens.

Key facts

Procedure
open
Contact
DZEM@tk.de
Contract period
1 Aug 2025 → 1 Aug 2027
Bids opened
31 Dec 2026, 22:59 GMT
Regime
publicSector
Category
supplies
  • The documents — every attachment, with its text extracted and searchable
  • Qualification — the notice scored against your company profile
  • Tracking and alerts — a pipeline for your bids, and the matching notices by email
  • Calendar export — the deadline as a calendar file
  • The API and MCP — the same record in your own tools and your AI assistant

Provenance

Source
ted-eu
Notice id
800748-2026
First seen
18 Nov 2026
Last updated
18 Nov 2026

Licence EU reuse — Commission Decision 2011/833/EU ↗

Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.

View at source ↗GET /api/v1/tenders/67c3177e-ec3f-40cd-a8bc-8fc12d7f895b

The source notice is authoritative — verify deadlines and documents there before bidding.